From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Latest News

Bearcast
premium content

Tom Winnifrith Bearcast: Highlands Natural - Renegade, Rum & Coke

In today's bearcast I look in detail at Highlands Natural Resources (HNR) a true POS. I cover Angus Energy (ANGS), Saffron Energy (SRON) and Advanced Oncotherapy (AVO). 

FLO

Flowtech Fluidpower – review as argues “successful fundraise of £10 million”

Writing in January on fluid power products supplier Flowtech (FLO) with the shares just below 130p, I noted that there looked potentially interesting value, but also “c.£13 million” of net debt and a downward forecast trend which deterred. The company has now announced a “successful fundraise of £10 million at 120p per share”

AVO
premium content

Advanced Oncotherapy forced to fess up on Death Spiral Provider Bracknor & Short selling

Heading to zero, serial liar Advanced Oncotherapy (AVO) has today called a GM to approve the issue of a blizzard of shares to obliterate its share price via death spiral. More on that later but the documentation throws up another issue other than the lies refered to earlier HERE, why will Advanced NOT come clean on short selling by death spiral provider Bracknor.

IGAS
premium content

Igas – more details on proposed refinancing, but has the company got enough bondholder support?

Having (quite correctly) been an out-and-out bear of AIM-listed and overindebted Igas Energy (IGAS) ever since we exposed the dealings of former trougher-in-chief Andrew “Piggy” Austin (before he was shown to the edge of the plank) the potential demise of the company has been on the radar. Here are ShareProphets we have flagged up the eventual destination of massive dilution for shareholders or just a round of toast and the company duly served up proposals for a refinancing at 4.5p. I’m still not completely convinced the board will pull off this deal but despite the dilution the terms proposed look to be a remarkable achievement by the new board – IF it can get it over the line.

AVO
premium content

Advanced Oncotherapy - here is a lie it published ahead of that last placing, and another on placing day

Advanced Oncotherapy (AVO) has today called its GM to approve the issuance of more shares to feed the Bracknor Death Spiral - more on that later for the document is, like the company, a joke. But first lets go to a big fat monstrous lie it told last year to help get that bailout placing away in September.

BKG

If You Agree the Building Trade Will Boom, Here Are Three Firms to Look At

Hello Share Trenders. I’m about 10% in cash at the mo. It’s out of the ordinary for me to have so much money not in shares, but even raving optimists have to take a bit of notice of the gloomsters who heavily outnumber me - many of which write on this glittering website. However, I have spent some of my cash reserve recently on shares in three companies in the house building game. You’ve probably read me being boringly bullish about this sector over the last year.

PMP

Portmeirion Group – looking through the 2016 results spin…

Shares in Portmeirion, Spode, Royal Worcester, Wax Lyrical and Pimpernel homewares group Portmeirion (PMP) are currently slightly lower despite it “delighted to be reporting an eighth consecutive year of record revenue”, this up by £8 million (11.7%) to £76.7 million…

BEG

Begbies Trading Statement - downgrade stance but sure don't sell!

Business recovery and property services group, Begbies Traynor (BEG) has updated on its third quarter (to end January), including that “we are encouraged to see some (insolvency) market stability”.

Roulette

AIM enjoys its least bad month for years

In February 2017, AIM lost six companies and gained six companies including 1 readmission leaving membership static at 973 companies. To see a month go by without a net loss of companies on "The world's most successful growth market" will be seen as a triumph and the champagne corks will be popping in Paternoster Square.

OPTI
premium content

Optibiotix - you wanted a big name deal - here you go: Sacco. Rejoice! Buy!

Oh ye of little faith! Ye who panicked that Optibiotix (OPTI) has not publicly announced that the big name party in the last deal was Tata. Fear not it will and there will be exciting news on that soon. Ye who thought there were no more deals. You were wrong and that is why we have been urging you to buy the shares at up to 80p again and again. The shares are now 71p-74p.

STM
premium content

STM Group – updates on “Budget Changes” as shares hit hard

Having been above 50p, shares in cross-border financial services provider STM Group (STM) are currently down to around 35p on the back of the Budget including, what the company describes as, “significant charges and tax implications for some individuals considering taking out a ‘Qualifying Recognised Overseas Pension Scheme’ transfer from a UK pension scheme

Bearcast
premium content

Tom Winnifrith Bearcast: An ethical fight as I Prepare for a day of nappy changing

On the agenda today, I start with a twitter spat with Hugo Rifkind a man who is where he is today thanks to who is Daddy is not his innate lack of talent and who is tweeting nonsense about a matter he has no experience of. After that thrill there is news on UK Investor Show, nappy changing, the ethical dimension in investing in pharma companies, Advanced Oncotherapy (AVO), W Resources (WRES),Domino's Pizza (DOM) and a discussion about residential property and non resident speculators.

LGO
premium content

LGO Buy at 2.45p target 22p says VSA - No I am not kidding

Just to please our own in house pet Bulletin Board Moron Wildes who is a big holder, I am delighted to publish a note from broker VSA out today initiating its coverage of LGO Energy (LGO) at 2.45p with a 22p price target. I kid you not. VSA is house broker so chuck in a pinch/bucket load of salt but 22p? I used to know a bloke called Edward Vaughan who was a bit bonkers. I do not think that it is the same Edward Vaughan who penned this note but whatever... in its full 16 page glory

EDEN
premium content

Eden Research – what’s with this Oxford Capital announcement? It’s dissolved – who got the warrants?

Eden Research (EDEN) yesterday released an odd RNS. Not so unusual was a statement of total voting rights. But it also contained a statement of outstanding warrants and options. Was the company trying to bury something whilst the city was watching yesterday’s Budget statement? At the centre of this lies Oxford Capital Limited, which was dissolved and struck off on 31 January of this year.

BLVN
premium content

Bowleven – did Artemis plunge the knife before bailing out to Crown and if so where is the TR-1?

A brief line in an announcement by Crown Ocean has caught my eye in the latest twist in the battle to remove the useless board of AIM-listed Bowleven (BLVN). The board’s supposedly flagship farm-out transaction, with which CEO Kevin Hart expressed pleasure, seems to me have placed a maximum valuation of around $25 million on the company’s $100 million spent on Bomono. But I wonder whether major institution Artemis has sold out of the 14 million shares the market was told it held on Monday. If so, where is the TR-1, and did Artemis vote the shares against the board ahead of selling them to Crown Ocean? 

AVO
premium content

Has Advanced Oncotherapy broken covenants on Metric loan already - will it be insolvent on March 31 or is it there already?

I am beginning to think that the 32p I invested in buying one share in Advanced Oncotherapy (AVO) may be dead money sooner than I think. The silence on certain matters relating to the £11 million it owes Metric is deafening and leads me to believe that on March 31 this company could be insolvent. Or is it already insolvent?  The first question is whether Advanced has breached covenants on the loan already and so is in technical default, i.e. insolvent. If that is the case investors should be told at once should they not. Perhaps hapless Nomad Stockdale might force a clarification of this matter?

RDSA

Here's How the Budget Will Affect a Shareholder Like You

Hello Share Masters. I’ve taken a long hard look at the budget from our point of view and found it improves the shareholder’s lot quite a bit. However, I’m no tax expert, so in case I’ve got anything wrong, please do your own research.

Cheryl_Cole

Our last share tip is 70% up in 11 days - our next hot tip is at NOON Wednesday - catch it & 2 more for just £5

That 70% gain is at the bid by the way - what you could sell the shares for! We have no need to bodge our satistics our tips are just good tips. And we are not advising readers to sell yet - we expect them to be banking gains of 100% plus on that one within weeks. That is what we like - share tips that deliver big gains fast!

Bearcast
premium content

Tom Winnifrith Bearcast: I am now officially at war with Advanced Oncotherapy and have bought 1 share in the POS

Yesterday I asked Advanced Oncotherapy (AVO) to answer 16 questions. I regret to say that as at 12 noon today now undertaking had been given to answer the questions and that therefore I am now at war. As such as I celebrated International Women's day by having a good looking 28 year old blonde run her fingers through my hair I decided to buy one share in this POS company. Bring on the EGM and AGM says The Sheriff of AIM and I hope that other folks out there will also buy one share so that we can get the mothers on this board to answer some very valid questions. In this podcast i also look at how if I was running the fraud at Eden (EDEN) I would buy some time before all is revealed. I also comment on Solo Oil (SOLO) and on the budget and our irresponsible chancellor Hammond who is the real villain of sterling weakness, not Brexit.    

LOOP

LoopUp – 2016 results emphasise “strong performance” & “positive outlook”, so why are the shares lower?

A 2016 results announcement from remote meetings technology group LoopUp (LOOP) includes “we're very pleased to report strong business performance and a positive outlook in our first set of annual results as a public company”. So why are the shares currently more than 3% lower, at 156.5p, in response?...

Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

Most Read in the Past Seven Days

That Was the Week that Was

 

CTAI

Catenai – monster dilution

Time left: 16:07:56